Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
European Journal of Nuclear Medicine & Molecular Imaging, 06/11/09
Krüger S et al. - In a study to compare diagnostic accuracy of 18F-fluorodeoxyglucose (FDG) PET/CT vs standard planar bone scintigraphy (BS) and 18F-labelled NaF (18F) PET for detection of bone metastases (BM) in non-small cell lung cancer (NSCLC), it was concluded that integrated 18F-FDG PET/CT is superior to BS in detection of osteolytic BM in NSCLC. PET/CT may obviate the need to perform additional BS or 18F PET in staging of NSCLC, which significantly reduces costs.
Methods- 18F-FDG PET/CT was performed in 126 pts with NSCLC.
- Within 7 days BS (n=58) or 18F PET (n=68) was performed.
- 18F-FDG PET/CT, BS and 18F PET were evaluated by 2 experienced readers.
- Lesions were graded on a scale from 1 (definite BM) to 5 (degenerative lesion), and equivocal lesions were determined as indifferent (grade 3).
- 92 pts showed degenerative lesions (grade 4/5) on PET/CT, BS or 18F PET.
- In 34 pts (27%), BM lesions were diagnosed (grades 1 and 2).
- In 13 of 18 pts, BM were concordantly diagnosed with PET/CT and 18F PET.
- PET/CT showed more BM vs 18F PET (53 vs 40).
- In 1 pt, 1 osteolytic BM was false-negative on 18F PET.
- 18F PET identified 4 pts with BM compared with negative findings on PET/CT.
- Of 16 pts, 11 had concordant findings of BM on PET/CT and BS.
- In 3 pts, BS was false-negative and in 2 pts BM were diagnosed as indifferent.
Related Articles
Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09
Relevance Score: 70%
Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer
European Journal of Radiology, 10/26/09
Relevance Score: 69%
Incidental Detection of Granulomatous Prostatitis by F-18 FDG PET/CT in a Patient with Bladder Cancer: A Rare Complication of BCG Instillation Therapy
Clinical Nuclear Medicine, 10/07/09
Relevance Score: 68%
FDG Uptake in a Rheumatoid Nodule With Imaging Appearance Similar to a Malignant Soft Tissue Tumor
Clinical Nuclear Medicine, 10/07/09
Relevance Score: 67%
Intraspinal Canal Neurolymphomatosis Detected by FDG-PET/CT
Clinical Nuclear Medicine, 10/07/09
Relevance Score: 67%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
Experimental and Clinical Endocrinology & Diabetes, 12/19/09
Flat epithelial atypia is a common subtype of B3 breast lesions and associated with noninvasive cancer but not with invasive cancer in final excision histology
Human Pathology, 12/19/09
Thyroid follicular neoplasm: Analysis by fine needle aspiration cytology, frozen section, and histopathology
Diagnostic Cytopathology, 12/18/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease
Cancer Research, 12/20/09
A small-cell lung cancer genome with complex signatures of tobacco exposure
Nature, 12/18/09
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
British Journal of Cancer, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


